202 related articles for article (PubMed ID: 6986559)
1. Complement-induced granulocyte aggregation: an unsuspected mechanism of disease.
Jacob HS; Craddock PR; Hammerschmidt DE; Moldow CF
N Engl J Med; 1980 Apr; 302(14):789-94. PubMed ID: 6986559
[No Abstract] [Full Text] [Related]
2. Complement-mediated leucoembolization: a mechanism of tissue damage during extracorporeal perfusions, myocardial infarction and in shock--a review.
Jacob HS
Q J Med; 1983; 52(207):289-96. PubMed ID: 6359225
[TBL] [Abstract][Full Text] [Related]
3. Sudden blindness in acute pancreatitis. Possible role of complement-induced retinal leukoembolization.
Jacob HS; Goldstein IM; Shapiro I; Craddock PR; Hammerschmidt DE; Weissmann G
Arch Intern Med; 1981 Jan; 141(1):134-6. PubMed ID: 7447575
[TBL] [Abstract][Full Text] [Related]
4. The stimulated granulocyte as an effector of immune injury or, the fickle phagocyte: friend or foe?
Hammerschmidt DE
J Miss State Med Assoc; 1981 Nov; 22(11):280-4. PubMed ID: 7310864
[No Abstract] [Full Text] [Related]
5. The role of activated complement and granulocytes in shock states and myocardial infarction.
Jacob HS
J Lab Clin Med; 1981 Nov; 98(5):645-53. PubMed ID: 7299236
[No Abstract] [Full Text] [Related]
6. Tissue damage caused by activated complement and granulocytes in shock lung, post perfusion lung, and after amniotic fluid embolism: ramifications for therapy.
Jacob HS; Hammerschmidt DH
Ann Chir Gynaecol Suppl; 1982; 196():3-9. PubMed ID: 6961880
[TBL] [Abstract][Full Text] [Related]
7. Complement-induced vascular leukostasis. Its role in tissue injury.
Jacob HS
Arch Pathol Lab Med; 1980 Dec; 104(12):617-20. PubMed ID: 6893656
[TBL] [Abstract][Full Text] [Related]
8. [Complement, granulocytes and pulmonary capillaries].
Solal-Celigny P; Meyohas MC
Rev Fr Mal Respir; 1983; 11(5):751-67. PubMed ID: 6361933
[TBL] [Abstract][Full Text] [Related]
9. Adult respiratory distress-like syndrome during hemodialysis: relationship between activation of complement, leukopenia, and release of granulocyte elastase.
Knudsen F; Nielsen AH; Pedersen JO; Grunnet N; Jersild C
Int J Artif Organs; 1985 Jul; 8(4):187-94. PubMed ID: 3850856
[TBL] [Abstract][Full Text] [Related]
10. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.
Craddock PR; Hammerschmidt D; White JG; Dalmosso AP; Jacob HS
J Clin Invest; 1977 Jul; 60(1):260-4. PubMed ID: 874088
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic ramifications of the interaction of complement, granulocytes, and platelets in the production of acute lung injury.
Jacob HS; Moldow CF; Flynn PJ; Weisdorf DJ; Vercellotti GM; Hammerschmidt DE
Ann N Y Acad Sci; 1982; 384():489-95. PubMed ID: 6953835
[TBL] [Abstract][Full Text] [Related]
12. [Validity of the granulocyte aggregation test for the evaluation of complement activation in the adult respiratory distress syndrome].
Ortolani O; Conti A; Minale F; Imperatore R; Mazzarella L
Boll Soc Ital Biol Sper; 1985 Aug; 61(8):1207-14. PubMed ID: 4063110
[No Abstract] [Full Text] [Related]
13. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.
Craddock PR; Fehr J; Dalmasso AP; Brighan KL; Jacob HS
J Clin Invest; 1977 May; 59(5):879-88. PubMed ID: 856872
[TBL] [Abstract][Full Text] [Related]
14. Acute exacerbation of idiopathic pulmonary fibrosis and fibroproliferative acute respiratory distress syndrome: similar disease, similar treatment?
Jantz MA
Respir Care; 2001 Jul; 46(7):664-5. PubMed ID: 11403697
[No Abstract] [Full Text] [Related]
15. High dose corticosteroids and cell-cell interactions.
Kjellström BT; Risberg B
Acta Chir Scand Suppl; 1985; 526():37-47. PubMed ID: 3911707
[TBL] [Abstract][Full Text] [Related]
16. Biochemical pathways of acute lung injury.
Lamy M; Deby-Dupont G; Pincemail J; Braun M; Duchateau J; Deby C; Van Erck J; Bodson L; Damas P; Franchimont P
Bull Eur Physiopathol Respir; 1985; 21(3):221-9. PubMed ID: 3873973
[TBL] [Abstract][Full Text] [Related]
17. Complement activation in adult respiratory distress syndrome treated with long-term extracorporeal CO2 removal.
Agostoni A; Cicardi M; Bergamaschini L; Gardinali M; Frangi D; Gattinoni L; Pesenti A
Trans Am Soc Artif Intern Organs; 1983; 29():227-30. PubMed ID: 6424303
[No Abstract] [Full Text] [Related]
18. Accentuated complement activation in patient plasma during the adult respiratory distress syndrome: a potential mechanism for pulmonary inflammation.
Langlois PF; Gawryl MS; Zeller J; Lint T
Heart Lung; 1989 Jan; 18(1):71-84. PubMed ID: 2783581
[TBL] [Abstract][Full Text] [Related]
19. The role of C3a in pulmonary alveoli following trauma.
Obertacke U; Joka T; Zilow G; Kirschfink M; Schmit-Neuerburg KP
Prog Clin Biol Res; 1989; 308():43-9. PubMed ID: 2789395
[No Abstract] [Full Text] [Related]
20. [Studying efficacy of remaxol in the treatment of respiratory distress syndrome under endotoxicosis conditions].
Vlasov AP; Nachkina EI; Grigor'eva TI; Tarasova TV; Potianova IV
Eksp Klin Farmakol; 2010 May; 73(5):23-6. PubMed ID: 20597366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
